Mandana Khalili, MD
|School||UCSF School of Medicine|
|Address||1001 Potrero Ave, SFGH 5|
San Francisco CA 94110
|UCSF||Mentor Development Program Certificate||2007||Medicine|
|UCSF||M.A.S||2005||Clinical Research, Department of Epidemiology and Biostatistics|
|University of Ottawa||M.D.||1992||Medicine|
|UCSF||2016||ZSFG Distinction in Medical Education Award Nomination|
|UCSF||2015||Academic Senate Distinction in Mentoring Award Nomination|
|NIH||2014||Mid-Career Investigator Award in Patient Oriented Research |
|UCSF||2013||Academic Senate Distinction in Mentoring Award Nomination|
|UCSF||2009||UCSF University Community Partnerships Council Service Learning Award |
|UCSF||2008||Longitudinal Clinical Experience Appreciation Certificate|
|Schering Oncology||2001||Recognizing Discovery and Innovation in 2001: Milestones in Hepatitis C, Hepatitis Innovation Award|
|Gastroenterology Research Group||2000||American Digestive Health Foundation, Martin Brotman Training and Transition Award|
|Canada||1988||Natural Sciences and Engineering Research Council Award|
|McGill University||1986||J.W. McConnell Entrance Award|
Chief of Clinical Hepatology, San Francisco General Hospital
Co-Director, Clinical and Translational Science Institute (CTSI)-Comprehensive Mentoring Program
Unit Director, CTSI- Mentor Consultation Services
My research focuses on natural history of chronic viral hepatitis (hepatitis B and hepatitis C), novel treatments for viral hepatitis, health services/health disparity in viral hepatitis, and evaluation of metabolic abnormalities and pathophysiology of diabetes within the context of hepatitis C and B. My group previously evaluated mechanisms of insulin resistance and secretion in a large cohort of hepatitis C infected patients, and is now examining how HCV affects insulin action among the high risk Latino population. We are studying insulin action over time, with and without HCV treatment, using direct measures of insulin secretion and insulin action. We are also studying the mechanisms of immune response to hepatitis C therapy through the Bay Area Hepatitis C Cooperative Study. Through community and participatory research, we are also evaluating hepatitis B management and liver cancer screening practices in hepatitis B-infected underserved populations including the impact of liver cancer screening on mortality. Our focus on health services research involves evaluation of the impact of educational interventions on patient and provider knowledge, attitudes, and barriers to hepatitis C and hepatitis B care as well as primary care-specialist care coordination and access to care for viral hepatitis. In addition, as one of the clinical research centers for the NIH-funded Hepatitis B Research Network, we are currently working on better understanding the natural history of chronic hepatitis B and the optimal long-term treatment for this disease.
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.